#United States #Alexandria #Bluesight #ShortageCheck

Bluesight Launches Innovative ShortageCheck Solution

In a groundbreaking move, Bluesight has unveiled its new technology solution, ShortageCheck, designed to address the pressing issue of drug shortages in hospitals. This innovative platform not only forecasts and tracks medicinal inventories but also actively manages the potentially dangerous stockouts that can compromise patient care.

According to Bluesight's 2025 Hospital Pharmacy Operations Report (HPOR), a staggering 75% of hospital respondents ranked drug shortages as their top challenge in delivering efficient and compliant care. With the cost and effort associated with managing these shortages doubling in just the past five years, the annual financial burden on healthcare systems has approached $900 million.

The ShortageCheck system continuously monitors over 20 real-time market signals, which include everything from sudden demand surges to fulfillment delays and nationwide usage trends. By tapping into data from more than 2,500 acute care hospitals, it can proactively identify early warning signs and predict potential shortages, delivering up to 90 days of lead time. This timely intervention allows healthcare providers to strategically allocate resources and devise plans to prevent disruptions in patient care.

Once a shortage is anticipated, hospital systems can assess the risks and impacts, emphasizing specific shortages that require immediate attention. Additionally, the platform boasts a built-in communication system that facilitates seamless coordination among teams, enhancing the decision-making process regarding inventory management.

Kevin MacDonald, the CEO and co-founder of Bluesight, underscores the critical nature of this launch, stating, “Shortage management has been one of the most critical pain points for our customers. When shortages occur unexpectedly, teams are left to scramble for alternatives, but with ShortageCheck, we're providing them the necessary foresight.” MacDonald emphasizes that this technology not only alleviates stress but can also significantly enhance operational efficiency during a time when rising drug costs and staff shortages are prevalent.

ShortageCheck is the latest addition to Bluesight's suite of hospital intelligence solutions, which also includes tools like KitCheck, CostCheck, and 340BCheck. Each of these tools aims to streamline complex aspects of healthcare operations, providing dramatic improvements in efficiency. For instance, clients can expect to restock their inventories 10x faster, eliminate approximately 4% of drug spend, and enhance the efficacy of their drug diversion detection by 6.6x. Furthermore, the platform offers a 70% savings in time dedicated to patient privacy protection initiatives.

For organizations ready to tackle the challenges posed by drug shortages, ShortageCheck presents a promising pathway forward. It embodies an essential shift towards data-driven decision-making in drug supply management, reflecting Bluesight's commitment to supporting hospitals in ensuring that they deliver uninterrupted patient care.

To explore more about ShortageCheck and the complete suite of Bluesight solutions, visit bluesight.com.

• ---

About Bluesight

Bluesight empowers hospital operations through intelligent solutions that simplify processes related to inventory management, procurement, and compliance. With over 2,400 hospitals in North America relying on these technologies, Bluesight plays a vital role in enhancing healthcare system efficiency and patient safety.